Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 46561. Отображено 100.
05-01-2012 дата публикации

Methods and compositions for modulating proline levels

Номер: US20120003207A1
Автор: Mike A. Clark
Принадлежит: ONCOPHARMACOLOGICS Inc

Methods and compositions for modulating amino acid levels in a subject are provided herein.

Подробнее
05-01-2012 дата публикации

Novel fructosyl peptide oxidase

Номер: US20120003678A1
Принадлежит: Kyowa Medex Co Ltd

A protein described in any one of [1] to [4] below is provided according to the present invention: [1] a protein comprising the amino acid sequence represented by SEQ ID NO: 1; [2] a protein comprising an amino acid sequence with one or more amino acid deletions, substitutions, or additions in the amino acid sequence represented by SEQ ID NO: 1, and having fructosyl peptide oxidase activity; [3] a protein comprising an amino acid sequence having 80% or higher homology to the amino acid sequence represented by SEQ ID NO: 1, and having fructosyl peptide oxidase activity; and [4] a protein having fructosyl peptide oxidase activity, which is produced by an expression plasmid harbored by the Escherichia coli XL1-Blue MRF' strain deposited under Accession No. FERM BP-11026.

Подробнее
19-01-2012 дата публикации

Enzymes and methods for producing omega-3 fatty acids

Номер: US20120016144A1
Принадлежит: Individual

The present invention relates generally to the field of recombinant fatty acid synthesis, particularly in transgenic plants. The application describes genes involved in fatty acid synthesis and provides methods and vectors for the manipulation of fatty acid composition of plant oils. In particular, the invention provides constructs for achieving the integration of multiple heterologous genes involved in fatty acid synthesis into the plant genome, such that the resulting plants produce altered levels of polyunsaturated fatty acids. Also described are methods for enhancing the expression of fatty acid biosynthesis enzymes by co-expressing a silencing suppressor within the plant storage organ.

Подробнее
19-01-2012 дата публикации

Process for the production of arachidonic acid and/or eicosapentaenoic acid

Номер: US20120017332A1
Принадлежит: BASF Plant Science GmbH

The present invention relates to a new process for the production of arachidonic acid and/or eicosapentaenoic acid in plants through the co-expression of a Δ-12-/Δ-15-desaturase, Δ-9-elongase, Δ-8-desaturase and a Δ-5-desaturase and a process for the production of lipids or oils having an increased content of unsaturated fatty acids, in particular ω-3 and ω-6 fatty acids having at least two double bonds and a 18 or 20 carbon atom chain length. Preferably the arachidonic acid and eicosapentaenoic acid are produced in at least a 1:2 ratio. The invention furthermore relates to the production of a transgenic plants, preferably a transgenic crop plant, having an increased content of arachidonic acid and/or eicosapentaenoic acid, oils or lipids containing C 18 - or C 20 -fatty acids with a double bond in position Δ5, 8, 9, 11, 12, 14, 15 or 17 of the fatty acid produced, respectively due to the expression of the Δ-12-/Δ-15-desaturase, of the Δ-9-elongase, of the Δ-8-desaturase and of the Δ-5-desaturase in the plant. The expression of the inventive Δ-12-/Δ-15-desaturase leads preferably to linoleic acid and linolenic acid as products having a double bond in the position

Подробнее
02-02-2012 дата публикации

Modified luciola cruciata luciferase gene and protein

Номер: US20120028257A1
Принадлежит: Marker Gene Technologies Inc

A codon optimized and stabilized luciferase gene based upon the sequence of the natural luciferase gene isolated from Luciola cruciata (Japanese firefly) and a novel recombinant DNA characterized by incorporating this new gene coding for a novel luciferase into a vector DNA for improved activities in mammalian cells, are disclosed. This new luciferase exhibits long-wavelength light emission, as well as improved thermostability and higher expression levels in mammalian cell systems, compared to native luciferase. Assays using this new enzyme for measuring various biological metabolic functions are described.

Подробнее
02-02-2012 дата публикации

Preparation of adipic acid

Номер: US20120028320A1
Принадлежит: DSM IP ASSETS BV

The invention relates to a method for preparing adipic acid, comprising converting alpha-ketoglutaric acid (AKG) into alpha-ketoadipic acid (AKA), converting alpha-ketoadipic acid into alpha-ketopimelic acid (AKP), converting alpha-ketopimelic acid into 5-formylpentanoic acid (5-FVA), and converting 5-formylpentanoic acid into adipic acid, wherein at least one of these conversions is carried out using a heterologous biocatalyst.The invention further relates to a heterologous cell, comprising one or more heterologous nucleic acid sequences encoding one or more heterologous enzymes capable of catalysing at least one reaction step in said method.

Подробнее
02-02-2012 дата публикации

Yeast organism producing isobutanol at a high yield

Номер: US20120028323A1
Принадлежит: Gevo Inc

The present invention provides recombinant microorganisms comprising an isobutanol producing metabolic pathway and methods of using said recombinant microorganisms to produce isobutanol. In various aspects of the invention, the recombinant microorganisms may comprise a modification resulting in the reduction of pyruvate decarboxylase and/or glycerol-3-phosphate dehydrogenase activity. In various embodiments described herein, the recombinant microorganisms may be microorganisms of the Saccharomyces clade, Crabtree-negative yeast microorganisms, Crabtree-positive yeast microorganisms, post-WGD (whole genome duplication) yeast microorganisms, pre-WGD (whole genome duplication) yeast microorganisms, and non-fermenting yeast microorganisms.

Подробнее
09-02-2012 дата публикации

Method for obtaining a singular cell model capable of reproducing in vitro the metabolic idiosyncrasy of humans

Номер: US20120034642A1

The method is based on the use of expression vectors coding for the sense and anti-sense mRNA of the Phase I and Phase II drug biotransformation enzymes showing a greatest variability in humans for transforming cells expressing reductase activity. Such vectors can modulate (increase or decrease) the individualized expression of an enzyme without affecting the other enzymes. This singular cell model can reproduce in vitro the metabolic idiosyncrasy of humans. It is applicable in the study of development of new drugs, specifically in the study of metabolism, potential idiosyncratic hepatotoxicity, medicament interactions, etc., of new drugs.

Подробнее
16-02-2012 дата публикации

Process for the stereoselective enzymatic reduction of keto compounds

Номер: US20120040425A1
Принадлежит: IEP GMBH

In a process for the stereoselective, in particular enantioselective enzymatic reduction of keto compounds to the corresponding chiral hydroxy compounds, wherein the keto compounds are reduced with an enantioselective, NADH-specific oxidoreductase, a polypeptide is used for reducing the keto compounds, which polypeptide exhibits an R-ADH-signature H-[P; A]-[I; A; Q; V; L]-[G; K]-R at positions 204-208 and the following further structural features in their entirety: (i) an N-terminal Rossmann-Fold GxxxGxG, (ii) an NAG-motif at position 87, (iii) a catalytic triad consisting of S 139, Y 152 and K 156, (iv) a negatively charged amino acid moiety at position 37, (v) two C-terminal motifs in the dimerization domain [A; S]-S-F and [V; I]-DG-[G; A]-Y-[T; C; L]-[A; T; S]-[Q; V; R; L; P], (vi) Val or Leu at position 159 (4 positions downstream of K 156), (vii) Asn at position 178, and (viii) a proline moiety at position 188.

Подробнее
01-03-2012 дата публикации

Recombinant microbial host cells for high eicosapentaenoic acid production

Номер: US20120052537A1
Принадлежит: EI Du Pont de Nemours and Co

Engineered strains of the oleaginous yeast Yarrowia lipolytica are disclosed herein that are capable of producing microbial oil comprising greater than 25 weight percent of eicosapentaenoic acid [“EPA”], an omega-3 polyunsaturated fatty acid, measured as a weight percent of dry cell weight.

Подробнее
08-03-2012 дата публикации

Hmg-coa reductase derived peptide and cosmetic or pharmaceutical composition containing same

Номер: US20120058952A1
Принадлежит: ISP Investments LLC

The present invention relates to a peptide of general formula (I): R 1 -(AA) n -X 1 -Gly-Glu-Leu-Ser-X 2 -X 3- (AA) p -R 2 , derived from human HMG-CoA reductase. The present invention also relates to a cosmetic or pharmaceutical composition comprising at least one peptide of general formula (I), in a physiologically suitable medium. The present invention further relates to the use of this novel peptide as an active principle that activates human HMG-CoA reductase in a cosmetic composition intended to strengthen the barrier function of the skin and to stimulate epidermal differentiation. The invention further applies to a cosmetic treatment method intended to prevent and/or combat the external stresses and signs of cutaneous aging.

Подробнее
22-03-2012 дата публикации

Method of Cloning Stable Stress Tolerant Superoxide Dismutase Using Universal Primers

Номер: US20120070835A1

The present invention relates to a method of cloning stable stress tolerant superoxide dismutase from diverse plant species using universal primers.

Подробнее
05-04-2012 дата публикации

Anti-il12rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders

Номер: US20120082681A1
Принадлежит: NOVARTIS AG

The present invention relates to antibodies that specifically bind to IL12Rβ1, the non-signal transducing chain of both the heterodimeric IL12 and IL23 receptors. The invention more specifically relates to specific antibodies that are IL12 and IL23 receptor antagonists capable of inhibiting IL12/1L18 induced IFNγ production of blood cells and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by inhibiting IFNγ production, IL12 and/IL23 signaling, such as rheumatoid arthritis, psoriasis or inflammatory bowel diseases or other autoimmune and inflammatory disorders.

Подробнее
05-04-2012 дата публикации

Method for tracing gram-negative bacteria inside animal model using stable and bioluminescence-based expression system therefor

Номер: US20120083016A1

A method of creating a biotechnological product and an efficient and stable bio-luminescence vector which could be used for tracking Gram-negative bacteria when distributing inside animal body are provided. Through conjugation, this auto-luminescence vector can be easily transmitted from bacteria to bacteria among Gram-negative bacteria, and may facilitate bacteria to be luminescence-labeled for subsequently analyzing the dynamic change of bio-luminescent bacteria within animal body in vivo. This system includes a lacZ promoter-driven luxABCDE, a high copy number of ColE1 replicon, and a high plasmid stability of the conjugative and broad host-ranged plasmid pSE34 from Salmonella enterica serovar Enteritidis Sal550. This resulting construct pSE-Lux1 can not only conjugatively transmit among bacteria with broad host range, but also stably maintain in bacteria to efficiently express the bio-luminescent luxABCDE without supplementing the subtract for luciferases and the antibiotics for plasmid selection.

Подробнее
19-04-2012 дата публикации

Archael laccases and multicopper oxidases (mcos) and their uses thereof

Номер: US20120094335A1

The subject invention pertains to a novel purified polypeptide having laccase activity and the nucleic acid sequences encoding the polypeptide. The disclosed polypeptide works at moderately high temperatures from below 20° C. to about 70° C., both acidic and alkaline pH conditions, high salt concentrations and in the presence of organo solvents. The high stability of the enzyme enables its wide applications under even extreme conditions. The invention also provides methods of producing the laccase enzyme.

Подробнее
19-04-2012 дата публикации

Method for production of chrysanthemum plant having delphinidin-containing petals

Номер: US20120096589A1

Disclosed are: a method for producing a chrysanthemum plant having delphinidin-containing petals using a transcriptional regulatory region for a chrysanthemum-derived flavanone 3-hydroxylase (F3H) gene; and a chrysanthemum plant, a progeny or a vegetative proliferation product of the plant, or a part or a tissue of the plant, the progeny or the vegetative proliferation product, and particularly a petal or a cut flower of the plant. In the method for producing a chrysanthemum plant having delphinidin-containing petals, a flavonoid 3′,5′-hydroxylase (F3′5′H) is caused to be expressed in a chrysanthemum plant using a transcriptional regulatory region for a chrysanthemum-derived flavanone 3-hydroxylase (F3H) gene.

Подробнее
26-04-2012 дата публикации

N-linked glycan biosynthesis modulators

Номер: US20120100609A1
Принадлежит: Individual

Provided herein are N-linked glycan inhibitors, including modulators of N-linked glycan glycosylation, mannosidase, an N-linked glycan N-acetylglucosaminyl transferase, an N-linked glycan fucosyl transferase, an N-linked glycan galactosyl transferase, an N-linked glycan sialyl transferase, an N-linked glycan sulfotransferase, N-linked glycan glycophosphotransferase or a combination thereof.

Подробнее
17-05-2012 дата публикации

Superoxide dismutase variants and methods of use thereof

Номер: US20120121568A1
Автор: Danica Chen, Xiaolei Qiu
Принадлежит: UNIVERSITY OF CALIFORNIA

The present disclosure provides variant superoxide dismutase polypeptides, compositions comprising the polypeptides, and nucleic acids comprising nucleotide sequences encoding the polypeptides. The present disclosure provides methods of reducing oxidative damage in a cell, tissue, or organ. The present disclosure provides methods of identifying agents that increase superoxide dismutase activity.

Подробнее
07-06-2012 дата публикации

Methods and Compositions for Treatment of Muscular Dystrophy

Номер: US20120141441A1
Принадлежит: Leland Stanford Junior University

The present disclosure provides methods for introducing a gene encoding a muscle membrane protein into a cell isolated from a subject to generate a genetically modified cell. The genetically modified cell may be introduced back, e.g., engrafted into the subject. The isolated cell may be additionally modified by introducing into the isolated cell a gene encoding one or more reprogramming transcription factors that induce the cell to form an induced pluripotent stem cell. The genetically modified cell may be differentiated in vitro to form muscle cell precursors before engrafting into the subject. Also provided are compositions comprising autologous cells isolated from a subject which cells comprise a muscle membrane protein gene integrated into a genome attachment site in the genome of the cell. The autologous cell may be an induced pluripotent cell or a mesenchymal stem cell, such as an adipose-derived mesenchymal stem cell (AD-MSC).

Подробнее
14-06-2012 дата публикации

Mesophilic and Thermophilic Organisms Modified to Produce Acrylate, and Methods of Use Thereof

Номер: US20120149077A1
Принадлежит: Mascoma Corp

The present invention provides for novel metabolic pathways leading to acrylate formation in a consolidated bio-processing system (CBP) where lignocellulosic biomass is efficiently converted to acrylate. In one such metabolic pathway, pyruvate is converted to lactate, which is converted to lactoyol-CoA, which is converted to acryloyl-CoA, and which is finally converted to acrylate. In another such metabolic pathway, pyruvate is converted to L-α-alanine, which is converted to L-aspartate, which is converted to β-alanine, which is converted to β-alanyl-CoA, which is converted to acryloyl-CoA, and which is finally converted to acrylate. In yet another metabolic pathway, pyruvate is converted to lactate, and then lactate is converted directly to acrylate. In certain aspects, the invention provides for heterologous expression of one or more enzymes in a mesophilic or thermophilic organism, such as Thermoanaerobacterium saccharolyticum or Clostridium thermocellutn , where the one or more enzymes functions within a novel metabolic pathway as described above to convert pyruvate to acrylate via lactate, or via β alanine and acryloyl-CoA.

Подробнее
14-06-2012 дата публикации

PEG-Urate Oxidase Conjugates and Use Thereof

Номер: US20120149083A1

A naturally occurring or recombinant urate oxidase (uricase) covalently coupled to poly(ethylene glycol) or poly(ethylene oxide) (both referred to as PEG), wherein an average of 2 to 10 strands of PEG are conjugated to each uricase subunit and the PEG has an average molecular weight between about 5 kDa and 100 kDa. The resulting PEG-uricase conjugates are substantially non-immunogenic and retain at least 75% of the uricolytic activity of the unmodified enzyme.

Подробнее
21-06-2012 дата публикации

Lipid Production

Номер: US20120151833A1
Принадлежит: Neste Oyj

The present invention relates to a genetically modified Acinetobacter host for lipid production. The Acinetobacter host has been genetically modified to be deficient of one or more of genes A) a gene encoding fatty acyl-CoA reductase (EC1.2.1.n2), wherein said host is capable of increased production of TAGs and/or of total lipids compared to the parent host; and/or B) a gene encoding lipase (EC:3.1.1.3), a gene encoding pyruvate dehydrogenase (EC:1.2.2.2), and/or gene ACIAD 2177, or functional equivalents of any of said genes, wherein said host is capable of increased production of wax esters and/or total lipids compared to the parent host.

Подробнее
21-06-2012 дата публикации

Preparation of alpha-ketopimelic acid

Номер: US20120156737A1
Принадлежит: DSM IP ASSETS BV

The invention relates to a method for preparing alpha-ketopimelic acid, comprising converting alpha-ketoglutaric acid into alpha-ketoadipic acid and converting alpha-ketoadipic acid into alpha-ketopimelic acid, wherein at least one of these conversions is carried out using a heterologous biocatalyst. The invention further relates to a heterologous cell, comprising one or more heterologous nucleic acid sequences encoding one or more heterologous enzymes capable of catalysing at least one reaction step in the preparation of alpha-ketopimelic acid from alpha-ketoglutaric acid.

Подробнее
28-06-2012 дата публикации

Renewable chemicals and fuels from oleaginous yeast

Номер: US20120164701A1
Принадлежит: Solazyme Inc

The invention provides methods of cultivating oil-bearing microbes using xylose alone or in combination with other depolymerized cellulosic material. Also provided are microorganisms comprising an exogenous gene encoding a polysaccharide degrading enzyme, such as a cellulase, a hemicellulase, a pectinase, or a driselase. Some methods of microbial fermentation are provided that comprise the use of xylose and depolymerized cellulosic materials for the production of oil-bearing microorgansims.

Подробнее
28-06-2012 дата публикации

Succinic acid production in a eukaryotic cell

Номер: US20120165569A1
Принадлежит: DSM IP ASSETS BV

The present invention relates to a recombinant eukaryotic cell selected from a yeast of a filamentous fungus comprising a nucleotide sequence encoding a NAD(H)-dependent fumarate reductase that catalyses the conversion of fumaric acid to succinic acid. The invention further relates to a process for the production of succinic acid wherein the eukaryotic cell according to the present invention is used.

Подробнее
05-07-2012 дата публикации

Polypeptides of Botryosphaeria Rhodina

Номер: US20120171189A1
Принадлежит: Novozymes AS

The invention relates to functional polypeptides secreted from Botryospaeria rhodina CBS 274.96.

Подробнее
05-07-2012 дата публикации

Method and marker for simple transformation and selection of recombinant protists

Номер: US20120172576A1
Автор: Matthias Rusing
Принадлежит: Individual

The present invention concerns a method for production of genetically modified (recombinant) protists without using negative selection markers, in which an auxotrophic mutant of the protist is produced, this mutant is then transformed with recombinant DNA containing at least one gene for complementation of the corresponding auxotrophy, and the resulting recombinant protist is finally selected on a minimal medium that makes possible growth of only the correspondingly complemented protist. The present invention also concerns an efficient method for production of proteins by protists so modified, in which the gene for the protein being produced is coupled to the marker gene.

Подробнее
19-07-2012 дата публикации

Reductase Enzymes

Номер: US20120184006A1
Принадлежит: Utah State University USU

In some embodiments, the present invention relates to isolated enzymes useful in reducing a fatty acyl-CoA to a corresponding fatty alcohol in a single biosynthetic step, polynucleotides encoding the enzymes, and methods for making and using these polynucleotides and enzymes. In some embodiments, the invention provides for isolated or recombinant enzymes capable of reducing a fatty acyl-CoA to a fatty alcohol. In still another embodiment, the invention provides for isolated or recombinant polynucleotides encoding an enzyme capable of reducing a fatty acyl-CoA to a fatty alcohol. In other embodiments, the invention provides for methods of making or using enzymes capable of reducing fatty acyl-CoA to a fatty alcohol, and methods of making using polynucleotides that encode the enzymes.

Подробнее
26-07-2012 дата публикации

Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes

Номер: US20120189604A1
Принадлежит: OX THERA INTELLECTUAL PROPERTY AB

The present invention comprises methods and compositions for the reduction of oxalate in humans, and methods for the purification and isolation of recombinant oxalate reducing enzyme proteins. The invention provides methods and compositions for the delivery of oxalate-reducing enzymes in particle compositions. The compositions of the present invention are suitable in methods of treatment or prevention of oxalate-related conditions.

Подробнее
26-07-2012 дата публикации

Method for Modifying Plant Architecture and Enhancing Plant Biomass And/Or Sucrose Yield

Номер: US20120192313A1
Принадлежит: Monsanto do Brasil Ltda

The present invention relates to methodology and constructs for modifying plant architecture and enhancing plant biomass and/or sucrose yield.

Подробнее
23-08-2012 дата публикации

Transformant and process for production thereof, and process for production of lactic acid

Номер: US20120214214A1
Принадлежит: Asahi Glass Co Ltd

The present invention relates to a transformant, containing a lactate dehydrogenase gene which is introduced into Schizosaccharomyces pombe as a host, in which a part of a gene cluster encoding a pyruvate decarboxylase in the Schizosaccharomyces pombe host is deleted or inactivated.

Подробнее
20-09-2012 дата публикации

Methods and means to alter lipid biosynthesis by targeting multiple enzymes to suborganelle domains

Номер: US20120240289A1
Принадлежит: BAYER CROPSCIENCE NV

Methods and means are provided to alter lipid biosynthesis in eukaryotic organisms by targeting at least two different polypeptides involved in fatty acid or lipid metabolism towards a similar or the same subdomain of an organelle, such as the endoplasmatic reticulum (ER), through fusion of the polypeptides with a similar or the same heterologous polypeptide targeting the chimeric fusion polypeptide to the mentioned subdomain.

Подробнее
27-09-2012 дата публикации

Polypeptides having modulatory effects on cells

Номер: US20120245092A1
Принадлежит: ECOLE NORMALE SUPERIEURE DE LYON

The present invention relates to peptides and polypeptides having the sequence SAVTFAVCAL or variants thereof, capable of binding to Calcineurin and/or to NS5A-TP2 and to their use in therapy, as well as to nucleic acid sequences and vectors encoding these peptides and polypeptides, and to cells comprising said polypeptides, nucleic acid sequences or vectors. The invention further relates to the use of the peptides, polypeptides or their derivatives to bring about phenotypic changes in mammalian cells, particularly to up-regulate calcineurin activity. The invention finally relates to a method for intracellular identification of substances which bind to calcineurin and which modulate the physiological effects of calcineurin.

Подробнее
01-11-2012 дата публикации

Transgenic animal overexpressing luciferase and preparation method thereof

Номер: US20120278911A1
Принадлежит: SNU R&DB FOUNDATION

The present disclosure provides a vector comprising a promoter and a luciferase gene having a nucleic acid sequence as disclosed in SEQ ID NO: 1; a fertilized egg transformed with the present vector; and a transgenic non-human animal overexpressing a luciferase gene from the vector and a method for preparing it. The vector and the animal of the present disclosure have a high expression rate for the luciferase gene, which confers high sensitivity for detection and thus useful for imaging analysis in a variety of research areas.

Подробнее
08-11-2012 дата публикации

Production of closed linear dna

Номер: US20120282283A1
Автор: Vanessa Hill
Принадлежит: Individual

An in vitro process for the production of closed linear deoxyribonucleic acid (DNA) comprises (a) contacting a DNA template comprising at least one protelomerase target sequence with at least one DNA polymerase in the presence of one or more primers under conditions promoting amplification of said template; and (b) contacting amplified DNA produced in (a) with at least one protelomerase under conditions promoting production of closed linear DNA. A kit provides components necessary in the process.

Подробнее
15-11-2012 дата публикации

Fungi adapted to metabolize phosphite as a source of phosphorus

Номер: US20120285210A1

System, including methods and compositions, for making and using fungi that are adapted transgenically to metabolize phosphite as a source of phosphorus for supporting growth.

Подробнее
15-11-2012 дата публикации

Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production

Номер: US20120289600A1
Принадлежит: EI Du Pont de Nemours and Co

Engineered strains of the oleaginous yeast Yarrowia lipolytica capable of producing greater than 50 weight percent of eicosapentaenoic acid [“EPA”], an ω-3 polyunsaturated fatty acid, in the total oil fraction are described. These strains over-express heterologous Δ9 elongases, Δ8 desaturases, Δ5 desaturases, Δ17 desaturases, Δ12 desaturases and C 16/18 elongases, and optionally over-express diacylglycerol cholinephosphotransferases. Preferred gene knockouts are also described. Production host cells, methods for producing EPA within said host cells, and products comprising EPA from the optimized Yarrowia lipolytica strains are claimed.

Подробнее
29-11-2012 дата публикации

Polyethylene glycolated superoxide dismutase mimetics

Номер: US20120301403A1
Принадлежит: Galera Therapeutics LLC

Compounds and methods for utilizing compounds comprising a superoxide dismutase mimetic covalently linked to polyethylene glycol. Methods are also provided for preparing a superoxide dismutase mimetic covalently linked to a polyethylene glycol, the methods comprising reacting an activated polyethylene glycol with a superoxide dismutase mimetic, or alternatively, reacting a superoxide dismutase mimetic with an activated polyethylene glycol. A method is also provided for preventing or treating a disease or disorder in which superoxide anions are implicated, comprising administering to a subject in need thereof, a therapeutically effective amount of a compound comprising a superoxide dismutase mimetic covalently linked to a polyethylene glycol. Methods of determining the safety and efficacy of the compounds are also provided. Methods for determining the safety and efficacy can include methods in lab animals and humans.

Подробнее
06-12-2012 дата публикации

Thermophilic thermoanaerobacter italicus subsp. marato having high alcohol productivity

Номер: US20120309065A1
Принадлежит: BIOGASOL IPR APS

Strict anaerobic thermophilic bacterium belonging to the group of Thermoanaerobacter italicus subsp. marato subsp. nov. and mutants and derivatives thereof. The bacterium is particularly suitable for the production of fermentation products such as ethanol, lactic acid, acetic acid and hydrogen from lignocellulosic biomass.

Подробнее
20-12-2012 дата публикации

Antiviral agent, abzyme, primer set, method for producing polynucleotide, and method for producing polypeptide

Номер: US20120322135A1
Принадлежит: JAPAN SCIENCE AND TECHNOLOGY AGENCY

The present invention provides: a novel antiviral agent containing a human antibody κ light chain, a novel human abzyme containing a human antibody κ light chain; a polynucleotide, a vector, and a transformant, each of which relating to the containing a human antibody κ light chain of the above; a primer set for effectively obtaining a human antibody κ light chain having a function as an antiviral agent or abzyme; and a method for producing a polynucleotide and a method for producing a polypeptide, each of which method utilizes the primer set.

Подробнее
27-12-2012 дата публикации

Method for increasing the activity of superoxide dismutase

Номер: US20120329131A1
Принадлежит: Individual

A method for increasing the activity of superoxide dismutase comprises steps of: liquid culture, by providing a strain of Bacillus subtilis and a liquid medium to carry out a fed-batch fermentation and to obtain a primary fermentation broth, wherein the liquid medium has 8 wt % to 10 wt % of maltose, 10 wt % to 15 wt % of soya powder and rest of water; and solid culture, by culturing the primary fermentation broth in a solid medium, which has solid substrate and maltose in a ratio of 10:1 to 20:1, to obtain a secondary fermentation broth with SOD in high activity, wherein the solid substrate contains wheat germ and water.

Подробнее
10-01-2013 дата публикации

Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like loxl for stimulating the formation of elastic fibers

Номер: US20130011902A1

The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. The invention relates notably to a method of identifying an active principle which stimulates the formation of elastic fibers. The aim of the invention is mainly to provide such a method of identification so as to provide compositions which enable stimulating the formation of elastic fibers.

Подробнее
10-01-2013 дата публикации

Cytokinin Oxidase-Like Sequences and Methods of Use

Номер: US20130014291A1
Принадлежит: PIONEER HI BRED INTERNATIONAL INC

Methods and compositions for modulating plant development are provided. Polynucleotide sequences and amino acid sequences encoding cytokinin oxidase polypeptides are provided. The sequences can be used in a variety of methods including modulating root development, modulating floral development, modulating leaf and/or shoot development, modulating seed size and/or weight, modulating tolerance under abiotic stress, and modulating resistance to pathogens. Polynucleotides comprising CKX promoters are also provided. The promoters can be used to regulate expression of a sequence of interest. Transformed plants, plant cells, tissues, and seed are also provided.

Подробнее
17-01-2013 дата публикации

Synthesis of Prazole Compounds

Номер: US20130017580A1
Принадлежит: Codexis Inc

The present disclosure relates to non-naturally occurring monooxygenase polypeptides useful for preparing prazole compounds, polynucleotides encoding the polypeptides, and methods of using the polypeptides.

Подробнее
17-01-2013 дата публикации

Nucleic acid construct comprising pyripyropene biosynthetic gene cluster and marker gene

Номер: US20130017581A1
Принадлежит: Individual

There is provided a nucleic acid construct comprising a pyripyropene biosynthetic gene cluster and a marker gene. The nucleic acid construct according to the present invention provides an inexpensive and highly productive method for producing pyripyropene.

Подробнее
24-01-2013 дата публикации

Genetically modified mice and engraftment

Номер: US20130022996A1

A mouse with a humanization of the mIL-3 gene and the mGM-CSF gene, a knockout of a mRAG gene, and a knockout of a mII2rg subunit gene; and optionally a humanization of the TPO gene is described. A RAG/II2rg KO/hTPO knock-in mouse is described. A mouse engrafted with human hematopoietic stem cells (HSCs) that maintains a human immune cell (HIC) population derived from the HSCs and that is infectable by a human pathogen, e.g., S. typhi or M. tuberculosis is described. A mouse that models a human pathogen infection that is poorly modeled in mice is described, e.g., a mouse that models a human mycobacterial infection, wherein the mouse develops one or more granulomas comprising human immune cells. A mouse that comprises a human hematopoietic malignancy that originates from an early human hematopoietic cells is described, e.g., a myeloid leukemia or a myeloproliferative neoplasia.

Подробнее
31-01-2013 дата публикации

Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies

Номер: US20130028881A1
Принадлежит: Shire Human Genetics Therapies Inc

This invention relates to methods and compositions for the diagnosis and treatment of Multiple Sulfatase Deficiency (MSD) as well as other sulfatase deficiencies. More specifically, the invention relates to isolated molecules that modulate post-translational modifications on sulfatases. Such modifications are essential for proper sulfatase function.

Подробнее
07-02-2013 дата публикации

Cells, nucleic acids, enzymes and use thereof, and methods for the production of sophorolipids

Номер: US20130035403A1
Принадлежит: EVONIK DEGUSSA GmbH

The invention relates to cells, nucleic acids, and enzymes, the use thereof for producing sophorolipids, and methods for producing sophorolipids.

Подробнее
14-02-2013 дата публикации

Compositions and methods for minimizing nornicotine synthesis in tobacco

Номер: US20130037040A1
Принадлежит: North Carolina State University

Compositions and methods for reducing the level of nornicotine and N′-nitrosonornicotine (NNN) in tobacco plants and plant parts thereof are provided. The compositions comprise isolated polynucleotides and polypeptides for a root-specific nicotine demethylases, CYP82E10, and variants thereof, that are involved in the metabolic conversion of nicotine to nornicotine in these plants. Compositions of the invention also include tobacco plants, or plant parts thereof, comprising a mutation in a gene encoding a CYP82E10 nicotine demethylase, wherein the mutation results in reduced expression or function of the CYP82E10 nicotine demethylase. Seed of these tobacco plants, or progeny thereof, and tobacco products prepared from the tobacco plants of the invention, or from plant parts or progeny thereof, are also provided. Methods for reducing the level of nornicotine, or reducing the rate of conversion of nicotine to nornicotine, in a tobacco plant, or plant part thereof are also provided. The methods comprise introducing into the genome of a tobacco plant a mutation within at least one allele of each of at least three nicotine demethylase genes, wherein the mutation reduces expression of the nicotine demethylase gene, and wherein a first of these nicotine demethylase genes encodes a root-specific nicotine demethylase involved in the metabolic conversion of nicotine to nornicotine in a tobacco plant or a plant part thereof. The methods find use in the production of tobacco products that have reduced levels of nornicotine and its carcinogenic metabolite, NNN, and thus reduced carcinogenic potential for individuals consuming these tobacco products or exposed to secondary smoke derived from these products.

Подробнее
14-02-2013 дата публикации

Elimination of N-Glycolylneuraminic Acid From Animal Products For Human Use

Номер: US20130039991A1
Принадлежит: UNIVERSITY OF CALIFORNIA

The application is in the field of transgenic (non-human) organisms, sialic acid chemistry, metabolism and antigenicity. More particularly, the invention is related to a method to produce Neu5Gc-free animals and products therefrom comprising disrupting the CMAH gene and thereby reducing or eliminating Neu5Gc from biological material of non-humans.

Подробнее
14-02-2013 дата публикации

Production of fatty alcohols with fatty alcohol forming acyl-coa reductases (far)

Номер: US20130040352A1
Принадлежит: Codexis Inc

The disclosure relates to methods of producing fatty alcohols from recombinant host cells comprising genes encoding heterologous fatty acyl-CoA reductase (FAR) enzymes. The disclosure further relates to FAR enzymes and functional fragments thereof derived from marine bacterium and particularly marine gamma proteobacterium such as Marinobacter and Oceanobacter ; polynucleotides encoding the FAR enzymes and vectors and host cells comprising the same.

Подробнее
21-02-2013 дата публикации

Grain Filling of a Plant Through the Modulation of NADH-Glutamate Synthase

Номер: US20130047300A1
Принадлежит: Genoplante Valor SAS

The invention relates to a method for increasing the grain filling of a plant, wherein said method comprises overexpressing in said plant a wheat NADH-dependent glutamate synthase, in order to increase the grain weight and/or the grain protein content.

Подробнее
28-02-2013 дата публикации

PEG-Urate Oxidase Conjugates and Use Thereof

Номер: US20130052677A1

A naturally occurring or recombinant urate oxidase (uricase) covalently coupled to poly(ethylene glycol) or poly(ethylene oxide) (both referred to as PEG), wherein an average of 2 to 10 strands of PEG are conjugated to each uricase subunit and the PEG has an average molecular weight between about 5 kDa and 100 kDa. The resulting PEG-uricase conjugates are substantially non-immunogenic and retain at least 75% of the uricolytic activity of the unmodified enzyme.

Подробнее
28-02-2013 дата публикации

Biocatalysts for ezetimibe synthesis

Номер: US20130052699A1
Принадлежит: Codexis Inc

The present disclosure relates to non-naturally occurring polypeptides useful for preparing Ezetimibe, polynucleotides encoding the polypeptides, and methods of using the polypeptides.

Подробнее
28-02-2013 дата публикации

Recombinant bilirubin oxidase and production method for the same

Номер: US20130052714A1
Принадлежит: Sony Corp

Disclosed is a method of producing a recombinant bilirubin oxidase, including a step wherein a bilirubin oxidase gene derived from imperfect filamentous fungus Myrothecium verrucaria is introduced to Escherichia coli and expression thereof is allowed. Also disclosed is a recombinant bilirubin oxidase obtained by this production method. This recombinant bilirubin oxidase has an enzymatic activity higher than that of a natural bilirubin oxidase derived from the imperfect filamentous fungus Myrothecium verrucaria.

Подробнее
28-02-2013 дата публикации

Plants having increased tolerance to herbicides

Номер: US20130053243A1
Принадлежит: BASF SE

The present invention refers to a method for controlling undesired vegetation at a plant cultivation site. The method comprises the steps of providing, at said site, a plant that comprises at least one nucleic acid comprising a nucleotide sequence encoding a wild-type hydroxyphenyl pyruvate dioxygenase or a mutated hydroxyphenyl pyruvate dioxygenase (mut-HPPD) which is resistant or tolerant to a coumarone-derivative herbicide and/or a nucleotide sequence encoding a wild-type homogentisate solanesyl transferase or a mutated homogentisate solanesyl tranferase (mut-HST) which is resistant or tolerant to a coumarone derivative herbicide, and then applying an effective amount of said herbicide to said plant cultivation site. The invention further refers to plants comprising mut-HPPD and to methods of obtaining such plants.

Подробнее
14-03-2013 дата публикации

Method for Increasing Microbial Catalase Production

Номер: US20130065292A1
Принадлежит: JIANGNAN UNIVERSITY

Disclosed are methods for increasing microbial catalase production. 1-10 g/L sodium hexametaphosphate was added to the culture medium between 30-40 hours of fermentation to inhibit proteinase activity and increase the production of catalase. This simple modification of fermentation procedure can result in up to 45% increase of the production of catalase.

Подробнее
14-03-2013 дата публикации

Cell-free preparation of carbapenems

Номер: US20130065878A1
Принадлежит: Greenlight Biosciences Inc

Provided herein are cell-free systems for generating carbapenems, e.g., a compound of the Formula (I): or salts thereof; wherein , R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are defined herein. Also provided are pharmaceutical compositions comprising a compound generated by the inventive cell-free system, and use of these compounds and compositions for the treatment of bacterial infections.

Подробнее
21-03-2013 дата публикации

L-LACTATE PRODUCTION IN CYANOBACTERIA

Номер: US20130071895A1
Принадлежит: PHOTANOL B.V.

A process of producing L-lactate as defined herein by feeding carbon dioxide to a culture of a cyanobacterial cell and subjecting said culture to light, wherein said cell is capable of expressing a nucleic acid molecule, wherein the expression of said nucleic acid molecule confer on the cell the ability to convert a glycolytic intermediate into L-lactate and wherein said nucleic acid molecule is under the control of a regulatory system which responds to light or to a change in the concentration of a nutrient in said culture. 1. A process of producing L-lactate by feeding carbon dioxide to a culture of a cyanobacterial cells and subjecting said culture to light , wherein said cell comprises a nucleic acid molecule coding for an enzyme capable of converting pyruvate to L-lactate , preferably for a L-lactate dehydrogenase , more preferably for a NAD(P)H-dependent L-lactate dehydrogenase , and wherein the expression of said nucleic acid molecule confers on the cell the ability to convert a glycolytic intermediate into L-lactate.2. A process according to claim 1 , wherein said nucleic acid molecule is under the control of a regulatory system which responds to light intensity.3. A process according to claim 1 , wherein said enzyme is substantially not sensitive towards oxygen inactivation.4. (canceled)5. A process according to claim 1 , wherein the nucleic acid molecule comprises a a nucleotide sequence encoding a L-lactate dehydrogenase claim 1 , wherein said nucleotide sequence is selected from the group consisting of:i. nucleotide sequences encoding a L-lactate dehydrogenase, said L-lactate dehydrogenase comprising an amino acid sequence that has at least 40% sequence identity with the amino acid sequence of SEQ ID NO:2;ii. nucleotide sequences comprising a nucleotide sequence that has at least 40% sequence identity with the nucleotide sequence of SEQ ID NO:1;iii. nucleotide sequences the reverse complementary strand of which hybridizes to a nucleic acid molecule of ...

Подробнее
21-03-2013 дата публикации

HOST CELLS AND METHODS FOR PRODUCTION OF ISOBUTANOL

Номер: US20130071898A1
Принадлежит: BUTAMAX(TM) ADVANCED BIOFUELS LLC

Provided herein are recombinant yeast host cells and methods for their use for production of isobutanol. Yeast host cells provided comprise an isobutanol biosynthetic pathway and at least one of reduced or eliminated aldehyde dehydrogenase activity, reduced or eliminated acetolactate reductase activity; or a heterologous polynucleotide encoding a polypeptide having ketol-acid reductoisomerase activity. 1. A recombinant host cell comprising an engineered isobutanol production pathway and [ [{'i': Bifidobacterium angulatum, Bifidobacterium dentium, Zymomonas mobilis, Clostridium beijerinckii', 'Anaerostipes caccae, '1. a polypeptide having at least about 90% identity to a KARI enzyme derived from or , or an active fragment thereof;'}, '2. a polypeptide having at least about 90% identity to SEQ ID NO: 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, or 65; or, 'i. a heterologous polypeptide with ketol-acid reductoisomerase (KARI) activity selected from the group consisting of, 'ii. a heterologous polynucleotide encoding the heterologous polypeptide with KARI activity of a); and, 'a. at least one of'}b. at least one host cell modification that enhances performance of the engineered isobutanol production pathway.2. The recombinant host cell of wherein the combination of a) and b) results in a synergistic increase in isobutanol production pathway performance.3. The recombinant host cell of wherein the host cell modification comprises reduced or eliminated aldehyde dehydrogenase expression or activity and reduced or eliminated acetolactate reductase expression or activity.4. The recombinant host cell of comprising reduced or eliminated aldehyde dehydrogenase expression or activity and reduced or eliminated acetolactate reductase expression or activity and wherein the heterologous polypeptide with KARI activity has a Kfor NADH less than 300 μM.5. The recombinant host cell of wherein the heterologous polypeptide with KARI activity has at least ...

Подробнее
21-03-2013 дата публикации

Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra

Номер: US20130072546A1
Принадлежит: Curna Inc

The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Methionine Sulfoxide Reductase A (MSRA), in particular, by targeting natural antisense polynucleotides of Methionine Sulfoxide Reductase A (MSRA). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of MSRA.

Подробнее
21-03-2013 дата публикации

Gene sequences and uses thereof in plants

Номер: US20130074202A1
Принадлежит: MONSANTO TECHNOLOGY LLC

This invention provides transgenic plant cells with recombinant DNA for expression of proteins that are useful for imparting enhanced agronomic trait(s) to transgenic crop plants. This invention also provides transgenic plants and progeny seed comprising the transgenic plant cells where the plants are selected for having an enhanced trait selected from the group of traits consisting of enhanced water use efficiency, enhanced cold tolerance, increased yield, enhanced nitrogen use efficiency, enhanced seed protein and enhanced seed oil. Also disclosed are methods for manufacturing transgenic seed and plants with enhanced traits.

Подробнее
21-03-2013 дата публикации

Precise breeding

Номер: US20130074222A1
Принадлежит: Simplot J R Co

The present invention relates to a method for identifying and isolating native plant nucleic acid sequences that may function as T-DNAs or T-DNA border-like sequences, effecting the transfer of one polynucleotide into another polynucleotide. The present invention also provides a modified tuber, such as a genetically modified mature tuber, that comprises at least one trait that is not exhibited by a non-modified tuber of the same species.

Подробнее
28-03-2013 дата публикации

Bacillus Pumilus Bilirubin Oxidase and Applications Thereof

Номер: US20130078662A1
Принадлежит:

The present invention relates to a novel bilirubin oxidase, to the method for preparing same and also to the use thereof in particular for assaying bilirubin and for using enzymatic biofuel cells. 1Bacillus pumilus. Purified bilirubin oxidase (BOD) , charadterized in that it has a percentage identity of at least 80% with respect to the BOD of of SEQ ID No. 2 , in that it catalyses the reaction for oxidation of bilirubin to biliverdin and in that it is bound to four copper atoms.2. Nucleic acid molecule claim 1 , characterized in that it codes an BOD according to .3. Nucleic acid molecUle according to claim 2 , having a sequence chosen from SEQ ID NO. 1 claim 2 , SEQ ID No. 5 or SEQ ID No. 7.4. Expression vector claim 2 , characterized in that it comprises a nucleic acid molecule according to .5Bacillus pumilus. Host cell expressing a BOD characterized in that it has a percentage identity of at least 80% with respect to the BOD of of SEQ ID No. 2 claim 4 , in that it catalyses the reaction for oxidation of bilirubin to biliverdin and in that it is bound to four copper atoms and further characterized in that it is transformed with an expression vector according to .6Bacillus pumilus. Method for preparing a BOD characterized in that it has a percentage identity of at least 80% with respect to the BOD of of SEQ ID No. 2 claim 4 , in that it catalyses the reaction for oxidation of bilirubin to biliverdin and in that it is bound to four copper atoms claim 4 , comprising the steps of:{'claim-ref': {'@idref': 'CLM-00005', 'claim 5'}, 'a) preparing host cells according to ;'}b) culturing host cells prepared in step a);c) lysing said host cells;d) treating the lysate obtained in step c) by affinity chromatography;e) recovering said purified BOD,{'i': 'Escherichia coli', 'sub': '21', 'characterized in that said host cell prepared in step a) is an BLStar strain transformed with the pFD1 vector and in that said culture carried out in step b) is a liquid-phase culture, with ...

Подробнее
28-03-2013 дата публикации

Method for protein production in filamentous fungi

Номер: US20130078674A1
Принадлежит: TEKNOLOGIAN TUTKIMUSKESKUS VTT

The present invention relates to a method for genetically modifying a filamentous fungus host for improved protein production. The method comprises that a filamentous fungus host is genetically modified to overexpress or to be deficient of specific genes. The invention relates also to the modified hosts. Furthermore, the invention relates to a method for improved production or for producing an improved composition of proteins, such as cellulases, hemicellulases, other proteins involved in the degradation of lignocellulosic material, or other proteins, in a filamentous fungus host. 1. A method to genetically modify a filamentous fungus host for improved protein production , said method comprising:{'i': Trichoderma, Aspergillus, Fusarium, Neurospora, Talaromyces, Phanerochaete, Chrysosporium', 'Penicillium, 'genetically modifying a filamentous fungus host to overexpress with increased amount or activity, or to be deficient with reduced or lacking amount or activity, of one or more genes selected from the group consisting of genes tre77513 (SEQ ID NO:1), tre80291 (SEQ ID NO:2), tre41573 (SEQ ID NO:3), tre74765 (SEQ ID NO:4), and tre64608 (SEQ ID NO:5); or of the closest homologue of at least one of said genes in or ; or of a fragment or derivative of any of said genes or other nucleotide sequence hybridizing under stringent conditions to at least one of said genes or said homologues, said host being capable of increased or decreased production of cellulase, hemicellulase, other proteins involved in degradation of lignocellulosic material and/or other proteins as compared to the parental strain.'}2Trichoderma, Aspergillus, Fusarium, Neurospora, Talaromyces, Phanerochaete, ChrysosporiumPenicillium. The method according to claim 1 , wherein the filamentous fungus host is genetically modified to overexpress one or more genes selected from the group consisting of genes tre77513 (SEQ ID NO:1) claim 1 , tre80291 (SEQ ID NO:2) claim 1 , tre41573 (SEQ ID NO:3) claim 1 , ...

Подробнее
04-04-2013 дата публикации

Native nad-dependent gapdh replaced with nadp-dependent gapdh plus nadk

Номер: US20130084600A1
Принадлежит: William Marsh Rice University

This invention is metabolically engineer bacterial strains that provide increased intracellular NADPH availability for the purpose of increasing the yield and productivity of NADPH-dependent compounds. In the invention, native NAD-dependent GAPDH is replaced with NADP-dependent GAPDH plus overexpressed NADK. Uses for the bacteria are also provided.

Подробнее
04-04-2013 дата публикации

NOVEL SOIL MICROORGANISM, NOVEL OXIDOREDUCTASE SEPARATED FROM THE SOIL MICROORGANISM, GENE ENCODING THE OXIDOREDUCTASE, AND METHOD FOR PRODUCING AGLYCONES USING THE MICROORGANISM, THE OXIDOREDUCTASE AND THE GENE

Номер: US20130084601A1
Принадлежит: AMOREPACIFIC CORPORATION

The present invention relates to the novel sp. GIN611 KCTC11708BP or to cell extracts thereof, to a novel oxidoreductase which exhibits a glycolytic activity, to a gene encoding the oxidoreductase, to a recombinant strain comprising recombinant vector proteins or to an expression vector encoding recombinant proteins, and to a method for the glycolysis of natural products using same as a biocatalyst. The present invention also relates to a method for producing aglycones from a variety of natural products using same. The novel oxidoreductase separated from the novel microorganism of the present invention does not belong to a glucosidase group but belongs to an oxidoreductase group, and has a glycolytic activity for natural products. The novel oxidoreductase oxidizes the sugar in the aglycones of natural products, thereby producing a variety of aglycones. 128-. (canceled)29Rhizobium. sp. having a capability to produce an oxidoreductase comprising an amino acid sequence of SEQ ID NO 3.30RhizobiumRhizobium. The sp. according to claim 29 , which is the sp. GIN611.31RhizobiumRhizobium. The sp. according to claim 29 , which is the sp. GIN611 KCTC 11708BP.32Rhizobium. A cell extract of the sp. having a capability to produce an oxidoreductase comprising an amino acid sequence of SEQ ID NO 3.33RhizobiumRhizobium. The cell extract according to claim 32 , wherein the sp. is sp. GIN611.34RhizobiumRhizobium. The cell extract according to claim 32 , wherein the sp. is sp. GIN611 KCTC 11708BP.35RhizobiumRhizobium. A method for deglycosylating a natural product using sp. having a capability to produce an oxidoreductase comprising an amino acid sequence of SEQ ID NO 3 claim 32 , or a cell extract of the sp. as a biocatalyst.36RhizobiumRhizobium. The method for deglycosylating a natural product according to claim 35 , wherein the sp. is sp. GIN611.37RhizobiumRhizobium. The method for deglycosylating a natural product according to claim 35 , wherein the sp. is sp. GIN611 KCTC 11708BP.38 ...

Подробнее
04-04-2013 дата публикации

NOVEL OXIDASE GENE AND METHOD FOR PRODUCING 3-INDOLE-PYRUVIC ACID BY UTILIZING THE GENE

Номер: US20130084610A1
Принадлежит:

It is an object of the present invention to provide a procedure for realizing inexpensive and simple production of 3-indole-pyruvic acid. A transformant is made using a polynucleotide having a specific nucleotide sequence encoding a protein having an oxidase activity, and oxidase is generated by culturing the transformant in a medium to accumulate the oxidase in the medium and/or the transformant. Further, tryptophan is converted into 3-indole-pyruvic acid in the presence of the transformant and/or a culture thereof to produce 3-indole-pyruvic acid. 1. A method for producing 3-indole-pyruvic acid , comprising converting tryptophan into 3-indole-pyruvic acid in the presence of an isolated recombinant host cell and/or a culture thereof ,wherein the recombinant host cell comprises a recombinant polynucleotide comprising a polynucleotide selected from the group consisting of the following (a) to (d):(a) a polynucleotide encoding a protein comprising the amino acid sequence of SEQ ID NO:2;(b) a polynucleotide encoding a protein which consists of an amino acid sequence comprising a substitution, deletion and/or insertion of one to ten amino acids in the amino acid sequence of SEQ ID NO:2 and has an L-Trp deaminase activity;(c) a polynucleotide encoding a protein which consists of an amino acid sequence having 95% or more homology to the amino acid sequence of SEQ ID NO:2 and has an L-Trp deaminase activity; and(d) a polynucleotide comprising the nucleotide sequence of nucleotide positions 61 to 1476 in the nucleotide sequence of SEQ ID NO:1.2. The method for producing 3-indole-pyruvic acid according to claim 1 , wherein the polynucleotide is (a) a polynucleotide encoding a protein comprising the amino acid sequence of SEQ ID NO:2.3. The method for producing 3-indole-pyruvic acid according to claim 1 , wherein the polynucleotide is (d) a polynucleotide comprising the nucleotide sequence of nucleotide positions 61 to 1476 in the nucleotide sequence of SEQ ID NO:1.4. The ...

Подробнее
11-04-2013 дата публикации

Industrial fatty acid engineering general system for modifying fatty acids

Номер: US20130089899A1
Принадлежит: Kiverdi Inc

Compositions and methods for a hybrid biological and chemical process utilizing chemotrophic microorganisms that converts syngas and/or gaseous CO2 and/or a mixture of CO2 gas and H2 gas into one or more desaturated hydrocarbons, unsaturated fatty acids, hydroxy acids, or diacids.

Подробнее
18-04-2013 дата публикации

ZWITTERION BUFFER CONTAINING COMPOSITIONS AND USES IN ELECTROANALYTICAL METHODS

Номер: US20130092536A1
Принадлежит: ROCHE DIAGNOSTICS OPERATIONS, INC.

Described herein are reagent compositions for detecting and/or measuring analytes in a test sample. In one embodiment, reagent compositions are described for detecting and/or measuring glucose in a sample. 1. A dried reagent composition comprising (a) one or more enzymes selected from the group consisting of glucose dehydrogenases (GDH) , glucose oxidoreductases , and combinations thereof; (b) one or more co-factors , co-enzymes , or a combination thereof for the one or more enzymes; (c) one or more mediators , mediator precursors , or a combination thereof; (d) one or more zwitterionic buffers; and (e) optionally one or more adjuvants.2. The reagent composition of wherein the enzyme is a wild-type GDH claim 1 , a mutant GDH claim 1 , or a GDH coenzyme.3. The reagent composition of wherein the GDH coenzyme is a FAD-GDH or a PQQ-GDH.4. The reagent composition of wherein the enzyme is a mutant GDH exhibiting maltose insensitivity.5. The reagent composition of wherein the enzyme is a mutant GDH exhibiting thermal stability.6. The reagent composition of wherein the zwitterionic buffer is PIPES or MOPS.7. The reagent composition of wherein the composition comprises a mediator precursor.8. The reagent composition of wherein the mediator precursor is a nitrosoaniline.9. The reagent composition of wherein the one or more adjuvants are selected from the group consisting of additional buffers claim 1 , stabilizers claim 1 , viscosity adjusting agents claim 1 , film forming agents claim 1 , thixotropic agents claim 1 , dispersants claim 1 , surfactants claim 1 , detergents claim 1 , pH adjusting agents claim 1 , and combinations thereof.10. The reagent composition of wherein at least one adjuvant is a film former.11. The reagent composition of wherein the film former is a polyvinyl acetate propionate co-polymer claim 10 , polyvinyl propionate dispersions claim 10 , or polyvinylpyrrolidone claim 10 , or a combination thereof.12. The reagent composition of wherein at least one ...

Подробнее
25-04-2013 дата публикации

BLEACHING OF PULP

Номер: US20130098570A1
Принадлежит: NOVOZYMES A/S

The use of a peroxidase and violuric acid, or a derivative thereof in the bleaching of pulp, such as paper materials, such as paper, linerboard, corrugated paperboard, tissue, towels, corrugated containers and boxes. The peroxidases of the invention are classified as EC 1.11.1.7. The effect of peroxidase is bleaching and de-inking of the pulp, e.g. the paper pulp and the resulting paper material. 128-. (canceled)30. The method of claim 29 , wherein U1 claim 29 , U2 and U3 are identical or different claim 29 , and are O or S; and R1 and R2 are identical or different claim 29 , and are hydrogen claim 29 , hydroxyl claim 29 , methyl claim 29 , ethyl claim 29 , phenyl claim 29 , benzyl claim 29 , formyl claim 29 , amino claim 29 , cyano claim 29 , nitroso claim 29 , methoxy and/or ethoxy.31. The method of claim 29 , wherein U1 claim 29 , U2 and U3 are O; and R1 and R2 are identical or different claim 29 , and are hydrogen claim 29 , hydroxyl claim 29 , methyl claim 29 , ethyl claim 29 , phenyl claim 29 , benzyl claim 29 , formyl claim 29 , amino claim 29 , cyano claim 29 , nitroso claim 29 , methoxy and/or ethoxy.32. The method of claim 29 , wherein the mediator is selected from 1-methylvioluric acid claim 29 , 1 claim 29 ,3-dimethylvioluric acid claim 29 , thiovioluric acid claim 29 , violuric acid claim 29 , and esters claim 29 , ethers or salts thereof.33. The method of claim 32 , wherein the mediator is violuric acid claim 32 , or a salt thereof.34. The method of claim 29 , wherein the pulp is wood pulp.35. The method of claim 29 , wherein the aqueous solution has a pH of from about 2.5 to about 6.36. The method of claim 29 , wherein the peroxidase comprises or consists of an amino acid sequence which has at least 80% identity to SEQ ID NO:1 claim 29 , SEQ ID NO:2 claim 29 , SEQ ID NO:3 claim 29 , or SEQ ID NO:4.37. The method of claim 29 , wherein the peroxidase comprises or consists of an amino acid sequence selected from the group consisting of SEQ ID NO:1 claim ...

Подробнее
25-04-2013 дата публикации

Glucose Dehydrogenase

Номер: US20130102016A1
Автор: Sode Koji
Принадлежит:

A modified pyrroloquinoline quinone glucose dehydrogenase that exhibits a high selectivity for glucose is provided. A modified pyrroloquinoline quinone glucose dehydrogenase is disclosed in which the amino acid residue G at Position 99 of a pyrroloquinoline quinone glucose dehydrogenase (PQQGDH) represented by SEQ ID NO: 1, or the amino acid residue G at Position 100 of the pyrroloquinoline quinone glucose dehydrogenase (PQQGDH) represented by SEQ ID NO: 3, is substituted by the amino acid sequence TGZN (where Z is SX, S, or N and X is any amino acid residue). The modified PQQGDH of the present invention may additionally comprise one or more mutations selected from the group consisting of Q192G, Q192A, or Q192S; L193X; E277X; A318X; Y367A, Y367F, or Y367W; G451C; and N452X (where X is any amino acid residue). 1. A modified pyrroloquinoline quinone glucose dehydrogenase (PGGGDH) , wherein the amino acid residue G at Position 100 of the PQQGDH represented by SEQ ID NO: 3 is substituted by the amino acid sequence TGZN (where Z is SX , S , or N , and X is any amino acid residue) , and from 1 to 10 of amino acid residues at Positions 1 to 99 or at Positions 101 to 480 of SEQ ID NO: 3 , may be substituted by any other amino acid residue(s).2. The modified pyrroloquinoline quinone glucose dehydrogenase according to claim 1 , wherein Z is SX where X is any amino acid residue.3. The modified pyrroloquinoline quinone glucose dehydrogenase according to claim 1 , wherein Z is SN.4. The modified pyrroloquinoline quinone glucose dehydrogenase according to claim 1 , further comprising one or more substitutions selected from the group consisting of the following amino acid substitutions:Q192G, Q192A, or Q192S;L193X where X is any amino acid residue;E277X where X is any amino acid residue;A318X where X is any amino acid residue;Y367A, Y367F, or Y367W; G451C; andN452X where X is any amino acid residue.5. The modified pyrroloquinoline quinone glucose dehydrogenase according to claim 4 ...

Подробнее
09-05-2013 дата публикации

Isolated luciferases and the use thereof

Номер: US20130115641A1
Принадлежит: Bayer Intellectual Property GmbH

The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.

Подробнее
09-05-2013 дата публикации

ENONE REDUCTASES

Номер: US20130115663A1
Принадлежит: CODEXIS, INC.

The disclosure relates to engineered enone reductase polypeptides having improved properties, polynucleotides encoding the engineered polypeptides, related vectors, host cells, and methods for making the engineered enone reductase polypeptides. The disclosure also provides methods of using the engineered enone reductase polypeptides for chemical transformations. 1. An enone reductase polypeptide comprising an amino acid sequence that is at least 80% identical to a reference sequence selected from the group consisting of SEQ ID NOs: 8 , 190 , 192 , 194 , 196 , 198 , 200 , 202 , 204 , 206 , 208 , 210 , 212 , 214 , 216 and 217; and wherein the amino acid sequence comprises one or more residue differences as compared to the reference sequence selected from the group consisting of: residue corresponding to X5 is E; residue corresponding to X10 is P; residue corresponding to X28 is P; residue corresponding to X38 is N or S; residue corresponding to X40 is L , Y , E or S; residue corresponding to X44 is Y; residue corresponding to X75 is L or S; residue corresponding to X83 is L , R , V , I , K , E , or M; residue corresponding to X117 is C , L , A , M , V , I , N , Q , E , F , or S; residue corresponding to X119 is P or V; residue corresponding to X122 is T; residue corresponding to X124 is G or P; residue corresponding to X147 is G; residue corresponding to X148 is R; residue corresponding to X153 is E; residue corresponding to X154 is R; residue corresponding to X179 is R; residue corresponding to X209 is D; residue corresponding to X240 is R; residue corresponding to X248 is C; residue corresponding to X251 is A; C , R , E , D , W , Y , R , S , V , G , L , or I; residue corresponding to X252 is H; residue corresponding to X255 is P; residue corresponding to X259 is G; residue corresponding to X294 is A; residue corresponding to X295 is T , N , or G; residue corresponding to X296 is G , F , A , S , R , E , Q , K , or I; residue corresponding to X297 is F; K; Y , W , G , ...

Подробнее
09-05-2013 дата публикации

TMEM195 ENCODES FOR TETRAHYDROBIOPTERIN-DEPENDENT ALKYLGLYCEROL MONOOXYGENASE ACTIVITY

Номер: US20130116304A1
Принадлежит:

The present invention relates to the provision of a pharmaceutical composition comprising a nucleic acid molecule encoding a alkylglycerol monooxygenase (TMEM195; glyceryl ether monooxygenase; EC 1.14.16.5). The present invention also provides for a method for producing said alkylglycerol monooxygenase (TMEM195; glyceryl ether monooxygenase; EC 1.14.16.5) polypeptides encoded by said polynucleotides. Moreover, the use of such polypeptides as well as of antagonists/inhibitors of such polypeptides in a medical setting (e.g. in from of a pharmaceutical composition) and methods for assessing the activity of a candidate molecule suspected of being an antagonist/inhibitor or agonist/activator in order to identify potential antagonists/inhibitors or agonists/activators of the polypeptide are also provided in the present invention. Finally, the present invention provides kits for carrying out said methods wherein the kits comprise polynucleotides and/or antibodies capable of detecting the activity of alkylglycerol monooxygenase. 1. A pharmaceutical composition comprising a nucleic acid molecule encoding a alkylglycerol monooxygenase comprising a polynucleotide selected from the group consisting of:(a) a polynucleotide sequence as shown in SEQ ID NO:1 or a fragment thereof;(b) a polynucleotide sequence encoding a polypeptide as shown in SEQ ID NO:2 or a fragment thereof;(c) a polynucleotide sequence which has at least 80% identity to the polynucleotides as defined in (a) or (b) encoding a functional alkylglycerol monooxygenase or a fragment thereof;(d) a polynucleotide sequence which hybridizes to the polynucleotide sequence of any one of (a) to (c) and whereby the coding strand encodes a functional alkylglycerol monooxygenase or a fragment thereof;(e) a polynucleotide sequence encoding a polypeptide as encoded by the nucleotide sequence of any one of (a) to (d) wherein at least one amino acid is deleted, substituted, inserted or added and whereby said polynucleotide encodes ...

Подробнее
09-05-2013 дата публикации

Method for Producing Unsaturated Omega-3-Fatty Acids in Transgenic Organisms

Номер: US20130116421A1
Принадлежит: BASF Plant Science GmbH

The present invention relates to nucleic acid sequences coding for polypeptides with ω-3-desaturase activity. The invention furthermore relates to nucleic acid constructs, vectors and organisms comprising at least one nucleic acid sequence according to the invention, at least one vector comprising the nucleic acid sequence and/or the nucleic acid constructs, and transgenic organisms comprise the abovementioned nucleic acid sequences, nucleic acid constructs and/or vectors. 1. An isolated nucleic acid molecule comprising a nucleic acid sequence encoding a polypeptide having ω-3-desaturase activity, wherein said polypeptide desaturates phospholipid-bound C20:4 polyunsaturated fatty acids. This application is a divisional of U.S. application Ser. No. 12/768,227, filed Apr. 27, 2010, which is a divisional of U.S. application Ser. No. 10/590,958, filed Aug. 25, 2006, now U.S. Pat. No. 7,777,098, which is the national stage application (under 35 U.S.C. 371) of PCT/EP2005/001865 filed Feb. 23, 2005, which claims benefit of German application 10 2004 009 458.6 filed Feb. 27, 2004. The entire contents of each of these applications are hereby incorporated by reference herein.The Sequence Listing associated with this application is filed in electronic format via EFS-Web and hereby incorporated by reference into the specification in its entirety. The name of the text file containing the Sequence Listing is Sequence_Listing1398700217. The size of the text file is 10 KB, and the text file was created on Jan. 9, 2013.The present invention relates to a process for production of unsaturated ω-3-fatty acids and to a process for production of triglycerides with an elevated content of unsaturated fatty acids, especially of ω-3-fatty acids having more than three double bonds. The invention relates to the production of a transgenic organism, preferably of a transgenic plant or of a transgenic microorganism, with an elevated content of unsaturated ω-3-fatty acids, oils or lipids having ω- ...

Подробнее
16-05-2013 дата публикации

METHOD FOR REDUCING COSTS OF ENZYMES IN BIOREFINERY

Номер: US20130118590A1
Принадлежит: SCIENTECK LLC

A business methodology for optimizing enzyme use rates and enzyme supply and reducing greenhouse gas emissions for an industrial process that employs enzymes as part of the production process by changing the concentration, specific gravity and/or activity of an enzyme prior to, and just-in-time for, the addition of said enzyme to a reactor wherein an enzyme-catalyzed reaction occurs. After collecting data that describes the extent to which enzyme consumption has decreased as a result of the change in concentration, specific gravity and/or activity of said enzymes, the enzyme user can pay to the provider of technology that allows enzyme consumption to decrease, a proportion of the savings. 1. A method for administering enzymes to a reactor on a just-in-time basis comprising:reformulating an enzyme concentrate to produce a reformulated enzyme solution of a desired concentration, specific gravity and/or activity, before addition of said enzyme to a bioreactor, at a rate that allows continuous delivery of said reformulated enzyme solution at the rate required to effect a desired enzyme-catalyzed reaction.2. A method for administering enzymes to a reactor according to claim 1 , wherein enzymes are added to the reactor continuously.3. A method for administering enzymes to a reactor according to claim 1 , wherein enzymes are added through a pipe ¼ inch in diameter to a substrate flowing at between 200 and 2000 Gallons/minute4. A method according to claim 3 , wherein the substrate is a slurry containing between 10 and 40% solids5. A method for administering enzymes to a reactor on a just-in-time basis comprising:reformulating an enzyme concentrate to the desired concentration, specific gravity and/or activity at a rate that allows continuous delivery of said reformulated enzyme at the rate required to effect a desired enzyme-catalyzed reaction;recording the data describing the degree to which the enzyme concentration, specific gravity and/or activity changes over time; ...

Подробнее
16-05-2013 дата публикации

Polypeptides Having Glucose Dehydrogenase Activity and Polynucleotides Encoding Same

Номер: US20130122149A1
Принадлежит: NOVOZYMES A/S

The present invention relates to isolated polypeptides having glucose dehydrogenase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. 1. An isolated polypeptide having glucose dehydrogenase activity , selected from the group consisting of:(a) a polypeptide having at least 60% sequence identity to the mature polypeptide of SEQ ID NO: 2;(b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 1 or SEQ ID NO: 3, or (ii) the full-length complement of (i);(c) a polypeptide encoded by a polynucleotide having at least 60% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1 or SEQ ID NO: 3;(d) a variant of the mature polypeptide of SEQ ID NO: 2 comprising a substitution, deletion, and/or insertion at one or more positions; and(e) a fragment of the polypeptide of (a), (b), (c), or (d) that has glucose dehydrogenase activity.2. The polypeptide of claim 1 , comprising an amino acid sequence having at least 80% identity to the mature polypeptide of SEQ ID NO: 2.3. The polypeptide of claim 1 , comprising an amino acid sequence having at least 85% identity to the mature polypeptide of SEQ ID NO: 2.4. The polypeptide of claim 1 , comprising an amino acid sequence having at least 90% identity to the mature polypeptide of SEQ ID NO: 2.5. The polypeptide of claim 1 , comprising an amino acid sequence having at least 95% identity to the mature polypeptide of SEQ ID NO: 2.6. The polypeptide of claim 1 , comprising or consisting of the amino acid sequence of SEQ ID NO: 2 claim 1 , the mature polypeptide of SEQ ID NO: 2 or a fragment thereof.7. The polypeptide of ...

Подробнее
16-05-2013 дата публикации

ENZYME THAT CATALYZES A PEPTIDE-FORMING REACTION FROM A CARBOXY COMPONENT AND AN AMINE COMPONENT, MICROBE PRODUCING THE SAME, AND A METHOD OF PRODUCING A DIPEPTIDE USING THE ENZYME OR MICROBE

Номер: US20130122544A1
Принадлежит: AJINOMOTO CO., INC.

DNA and recombinant DNA that encode a peptide-forming enzyme, a method for producing a peptide-forming enzyme, and a method for producing a dipeptide are disclosed. A method for producing a dipeptide includes producing a dipeptide from a carboxy component and an amine component by using a culture of a microbe belonging to the genus and having the ability to form the dipeptide from the carboxy component and the amine component, a microbial cell separated from the culture, treated microbial cell product of the microbe or a peptide-forming enzyme derived from the microbe. 1. An isolated DNA encoding a protein selected from the group consisting of (K) , (L) , (W) , and (X) , wherein said protein has an amino acid sequence defined as follows:(K) the amino acid sequence consisting of amino acid residues numbers 18 to 644 of SEQ ID NO:27,(L) an amino acid sequence which includes substitution, deletion, insertion, and/or addition, of one to 30 amino acids in the amino acid sequence consisting of amino acid residues numbers 18 to 644 of SEQ ID NO:27, and has at least 50% of the peptide-forming activity of a protein corresponding to unmutated amino acid residue numbers 18 to 644 of SEQ ID NO:27 at 50° C. and a pH of 8,(W) the amino acid sequence consisting of SEQ ID NO:27, and(X) an amino acid sequence which includes substitution, deletion, insertion, and/or addition, of one to 30 amino acids in the amino acid sequence consisting of SEQ ID NO:27, and has at least 50% of the peptide-forming activity of a protein corresponding to unmutated SEQ ID NO:27 at 50° C. and a pH of 8,oran isolated DNA selected from the group consisting of (k), (k2), and (w), wherein said DNA has a nucleotide sequence defined as follows:(k) a nucleotide sequence consisting of nucleotide numbers 104 to 1888 of SEQ ID NO:26,(k2) a nucleotide sequence that hybridizes under stringent conditions with a DNA having a nucleotide sequence complementary to a nucleotide sequence consisting of nucleotide numbers ...

Подробнее
16-05-2013 дата публикации

Mutant delta-5 desaturases and their use in making polyunsaturated fatty acids

Номер: US20130122558A1
Принадлежит: EI Du Pont de Nemours and Co

The present invention relates to mutant Δ5 desaturases, which have the ability to convert dihomo-γ-linolenic acid [DGLA; 20:3 ω-6] to arachidonic acid [ARA; 20:4 ω-6] and/or eicosatetraenoic acid [ETA; 20:4 ω-3] to eicosapentaenoic acid [EPA; 20:5 ω-3] and which possess at least one mutation within the HPGG motif of the cytochrome b 5 -like domain. Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding Δ5 desaturases, along with a method of making long chain polyunsaturated fatty acids [“PUFAs”] using these mutant Δ5 desaturases in oleaginous yeast, are disclosed.

Подробнее
16-05-2013 дата публикации

Tal effector-mediated dna modification

Номер: US20130122581A1

Materials and Methods related to gene targeting (e.g., gene targeting with transcription activator-like effector nucleases; “TALENS”) are provided.

Подробнее
23-05-2013 дата публикации

LACCASES FOR BIO-BLEACHING

Номер: US20130126110A1
Принадлежит:

Provided herein are isolated laccase enzymes and nucleic acids encoding them. Also provided are mediators for laccase reactions. Also provided herein are methods for using laccases to oxidize lignins and other phenolic and aromatic compounds, such as for bio-bleaching and decolorization of wood pulp under high temperature and pH conditions to facilitate a substantial reduction in use of bleaching chemicals, as well as for treatment of fibers. 1. An isolated polynucleotide , comprising: a sequence that comprises at least 80% sequence identity with the sequence of SEQ ID NO: 3 , wherein said polynucleotide encodes a polypeptide comprising laccase activity , oxidizes lignin under conditions of pH greater than or equal to pH 8.0 , and retains laccase activity for at least about 5 minutes at greater than or equal to 60° C.2. The isolated polynucleotide of claim 1 , wherein said polynucleotide comprises a sequence that shares at least 90% sequence identity with SEQ ID NO: 3.3. The isolated polynucleotide of claim 1 , wherein said polynucleotide comprises a sequence that shares at least 95% sequence identity with SEQ ID NO: 3.4. The isolated polynucleotide of claim 1 , wherein said polynucleotide comprises a sequence that shares at least 97% sequence identity with SEQ ID NO: 3.5. The isolated polynucleotide of claim 1 , wherein said polynucleotide comprises a sequence that shares at least 99% sequence identity with SEQ ID NO: 3.6. The isolated polynucleotide of claim 1 , wherein said isolated polynucleotide comprises a sequence that encodes the polypeptide of SEQ ID NO: 4.7. The isolated polynucleotide of claim 1 , comprising a polynucleotide sequence of SEQ ID NO: 3.8. The isolated polynucleotide of claim 7 , wherein the isolated polynucleotide comprises a sequence that encodes the polypeptide of SEQ ID NO: 4.11. The method of claim 10 , further comprising contacting the phenolic or aromatic substrate with a mediator selected from the group consisting of violuric acid; 2 ...

Подробнее
23-05-2013 дата публикации

Barley lipoxygenase 1 gene, method of selecting barley variety, material of malt alcoholic drinks and process for producing malt alcoholic drink

Номер: US20130129862A1
Принадлежит: Sapporo Breweries Ltd

A selection method for barley lipoxygenase-1 deficient barley, comprising a step of distinguishing the barley lipoxygenase-1 deficient barley by whether or not the guanine at the splicing donor site of the 5th intron of the barley lipoxygenase-1 gene is mutated to a different base; and a method for production of malt alcoholic beverages using a material for malt alcoholic beverages derived from barley obtained by the selection method.

Подробнее
23-05-2013 дата публикации

PROTEIN-ENCLOSED CARBON NANOTUBE FILM, AND SENSOR AND POWER-GENERATING DEVICE EACH EQUIPPED WITH THE CARBON NANOTUBE FILM AS ELECTRODE

Номер: US20130130230A1
Принадлежит:

The present invention answers the demands of power generating device and biosensor development and provides a flexible, free-standing type protein containing carbon nanotube film, and a sensor and power generating device each equipped with the carbon nanotube film as an electrode. According to the present invention a carbon nanotube free standing film is provided including a carbon nanotube aggregate formed by aggregating a plurality of carbon nanotubes, and a plurality of enzymes included between the plurality of carbon nanotubes. The carbon nanotube film may include a different protein to the enzyme and may include a surfactant agent between the plurality of carbon nanotubes. 1. A carbon nanotube free standing film comprising:a carbon nanotube aggregate formed by aggregating a plurality of carbon nanotubes; anda plurality of enzymes included between the plurality of carbon nanotubes.2. The carbon nanotube free standing film according to claim 1 , wherein a different protein to the enzyme is included.3. The carbon nanotube free standing film according to claim 1 , wherein a surfactant is included between the plurality of carbon nanotubes.4. The carbon nanotube free standing film according to claim 1 , wherein a plurality of mediator molecules is included between the plurality of carbon nanotubes.5. The carbon nanotube free standing film according to claim 1 , wherein the enzyme is an oxidase or a dehydrogenase.6. The carbon nanotube free standing film according to claim 1 , wherein the carbon nanotube aggregate includes a surface area of 600 m/g or more and 2 claim 1 ,600 m/g or less claim 1 , a weight density of 0.002 g/cmor more and 0.2 g/cmor less claim 1 , and a pore size distribution maximum of 5 nm or more and 100 nm or less.7. The carbon nanotube free standing film according to claim 1 , wherein a part is included in which the enzyme is arranged in one column in a parallel direction to a length direction of the carbon nanotube at a space enclosed by 4 of the ...

Подробнее
23-05-2013 дата публикации

PLANT CYTOCHROME P450

Номер: US20130133105A1
Принадлежит: GlaxoSmithKline Australia Pty Limited

This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules. 1. An isolated nucleic acid molecule that encodes a cytochrome P450 polypeptide wherein said nucleic acid molecule comprises or consists of a nucleotide sequence selected from the group consisting of:i) a nucleotide sequence as represented by the sequence in SEQ ID NO: 1, 2, 3, 4, 5, 6 or 7;ii) a nucleotide sequence wherein said sequence is degenerate as a result of the genetic code to the nucleotide sequence defined in (i);iii) a nucleic acid molecule the complementary strand of which hybridizes under stringent hybridization conditions to the sequence in SEQ ID NO: 1, 2, 3, 4, 5, 6 or 7 wherein said nucleic acid molecule encodes a cytochrome P450 polypeptide;iv) a nucleotide sequence that encodes a polypeptide comprising an amino acid sequence as represented in SEQ ID NO: 8, 9, or 10; andv) a nucleotide sequence that encodes a polypeptide comprising an amino acid sequence wherein said amino acid sequence is modified by addition deletion or substitution of at least one amino acid residue as represented in iv) above and which has retained or enhanced cytochrome P450 activity.2. The isolated nucleic acid molecule according to claim 1 , wherein said nucleic acid molecule comprises or consists of a nucleotide sequence as represented in SEQ ID NO: 1 claim 1 , 2 claim 1 , 3 claim 1 , 4 claim 1 , 5 claim 1 , 6 or 7.3. An isolated polypeptide selected from the group consisting of:i) a polypeptide comprising or consisting of an amino acid sequence as represented in SEQ ID NO: 8, 9, or 10; andii) a modified polypeptide comprising or consisting of a modified amino acid sequence wherein said polypeptide is modified by addition deletion or substitution of at least one amino acid residue of the sequence ...

Подробнее
23-05-2013 дата публикации

Genes encoding nematode toxins

Номер: US20130133107A1
Принадлежит: Athenix Corp

Compositions and methods for conferring nematicidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions including a coding sequence for nematicidal polypeptides are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also include transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated nematicidal nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for isolated nucleic acid molecules including nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO:4, 5, 8, 9, 13, 14, 47, 48, or 49, the nucleotide sequence set forth in SEQ ID NO:1, 2, 3, 6, 7, 10, 11, 12, 15, 45, or 46, as well as variants and fragments thereof.

Подробнее
06-06-2013 дата публикации

Enzyme/carbon structure complex, method for preparing same, and use thereof

Номер: US20130143130A1
Автор: Jungbae Kim

Disclosed is a composite of enzyme and carbon structure. In the composite of enzyme and carbon structure, a significantly large amount of an enzymeis immobilized on the surface of carbon structures without the formation of chemical bonds (particularly, covalent bonds) between the enzyme molecules and the carbon structures. Since the surface of the carbon structures does not need to be modified to form chemical bonds, the electrical conductivity of the composite of enzyme and carbon structure is not reduced and the stability of the composite is maintained high even after the passage of a long time in various environments. Therefore, the use of the composite of enzyme and carbon structure enables the fabrication of various devices, such as biosensors and biofuel cells, with markedly improved performance as compared to the use of conventional enzyme/carbon structure composites.

Подробнее
06-06-2013 дата публикации

FUSION PROTEIN HAVING LUMINESCENCE ACTIVITY

Номер: US20130143233A1
Принадлежит: JNC CORPORATION

The fusion protein comprising (1) a first region comprising the amino acid sequence of SEQ ID NO: 18 and (2) a second region comprising an amino acid sequence for a polypeptide containing at least one cysteine residue for binding to other useful compound via the thiol group can be modified by chemical modification, and thus has a high catalytic ability for a luminescence activity and is highly available for general purposes. 128-. (canceled)29. A polynucleotide comprising a polynucleotide encoding the fusion protein comprising: (a) a region consisting of the amino acid sequence of SEQ ID NO: 18;', '(b) a region consisting of the amino acid sequence of SEQ ID NO: 18 wherein 1 to 10 amino acids are deleted, substituted, inserted and/or added and having a catalytic ability for a luminescence activity with a luciferin which is a substrate;', '(c) a region consisting of an amino acid sequence having at least 90% homology to the amino acid sequence of SEQ ID NO: 18 and having a catalytic ability for a luminescence activity with a luciferin which is a substrate; and,', "(d) a region consisting of an amino acid sequence encoded by a polynucleotide which hybridizes under high stringent conditions to a polynucleotide consisting of a nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO: 17 and having a catalytic ability for a luminescence activity with a luciferin which is a substrate, wherein the high stringent conditions are 5×SSC, 5×Denhardt's solution, 0.5% (w/v) SDS, 50% (v/v) formamide and 50° C.; and,"], '(1) a first region selected from the group consisting of (a) to (d) below (e) a region consisting of the amino acid sequence of SEQ ID NO: 20;', '(f) a region comprising the amino acid sequence of SEQ ID NO: 20 wherein 1 to 3 amino acids are deleted, substituted, inserted and/or added and having at least one cysteine residue for binding to other useful compound via the thiol group;', '(g) a region comprising an amino acid sequence having at least ...

Подробнее
06-06-2013 дата публикации

Novel expression-regulating sequences and expression products in the field of filamentous fungi

Номер: US20130143271A1
Принадлежит: Dyadic International USA Inc

The invention pertains to novel proteins corresponding to Chrysosporium glycosyl hydrolases of families 7 and 10, exhibiting a minimum aminoacid identity of 70 and 75%, respectively, with the amino acid sequence of SEQ ID No's 2 and 4, and to a protein corresponding to a Chrysosporium glyceraldehyde phosphate dehydrogenase, exhibiting at least 86% amino acid identity with the partial amino acid sequence of SEQ ID No. 6. The invention further relates to nucleic acid sequences encoding these proteins, and especially to promoter sequences regulating the expression of the corresponding genes. The preferred host for expressing these genes is a fungus, especially a Chrysosporium strain.

Подробнее
06-06-2013 дата публикации

FLAVIN ENZYME HAVING FLAVONOL 8-HYDROXYLASE ACTIVITY AND USE THEREOF

Номер: US20130145496A1
Автор: SUZUKI Hideyuki
Принадлежит: SUNTORY HOLDINGS LIMITED

The purpose of the present invention is to provide a novel flavonol 8-hydroxylase. The present invention relates to a flavin enzyme protein having a flavonol 8-hydroxylase activity, and a polynucleotide etc. encoding the same, and so on. The present invention provides: a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1 or 3; a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID No. 2; an expression vector and transformant comprising the polynucleotide; a method for screening a plant which blooms one or more yellow coloured flowers by using the polynucleotide; a method for producing a plant which blooms one or more yellow coloured flowers by introducing the polynucleotide into host cells; and a method for producing a flavin enzyme protein having a flavonol 8-hydroxylase activity, using the transformant. 1. A polynucleotide according to any one selected from the group consisting of (a) to (e) below:(a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1 or 3;(b) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2;(c) a polynucleotide encoding a flavin enzyme protein consisting of an amino acid sequence wherein 1 to 100 amino acids are deleted, substituted, inserted and/or added in the amino acid sequence of SEQ ID NO: 2, and having a flavonol 8-hydroxylase activity;(d) a polynucleotide encoding a flavin enzyme protein having an amino acid sequence having at least 70% identity with the amino acid sequence of SEQ ID NO: 2, and having a flavonol 8-hydroxylase activity; and,(e) a polynucleotide that hybridizes to a polynucleotide consisting of a nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO: 1 or 3 under stringent conditions, and that encodes a flavin enzyme protein having a flavonol 8-hydroxylase activity.2. The polynucleotide according to claim 1 , which is either one defined in (f) or (g) below:(f) a polynucleotide encoding a flavin enzyme ...

Подробнее
13-06-2013 дата публикации

Optimization of Lipid Synthesis and Accretion

Номер: US20130149754A1

The present invention relates to a novel mutant strain of yeast, particularly a strain of Yarrowia lipolytica , which is capable of accumulating a large quantity of lipids. Said strain is deficient in the beta-oxidation of fatty acids and overexpresses the GPD1 gene. Preferably, the mutant strains, which do not express the GUT2 gene and which are deficient for the beta-oxidation of fatty acids, do not express the POX2 to POX5 genes, very preferably the POX2 to 6 genes. The invention also relates to a method for obtaining the strains of yeast according to the invention and to the use of said strains in the production of lipids.

Подробнее
13-06-2013 дата публикации

Whole-Cell Biotransformation Of Fatty Acids To Obtain Fatty Aldehydes Shortened By One Carbon Atom

Номер: US20130149756A1
Принадлежит: SYMRISE AG

The present invention relates to the area of producing aliphatic aldehydes with 5 to 31 carbon atoms, in particular by microbial conversion of corresponding aliphatic fatty acids with 6 to 32 carbon atoms. The invention also relates to enzymes for catalysing a conversion reaction of this type and nucleic acids coding for this. 1. A method for producing an aldehyde with 5 to 31 carbon atoms comprising:providing microorganism cells containing a dioxygenase;applying a conversion medium containing a fatty acid with 6 to 32 carbon atoms to the microorganism cells; andconverting the fatty acid to the aldehyde by means of the dioxygenase.2. The method according to claim 1 , wherein the dioxygenase is an alpha-dioxygenase.3. The method according to claim 2 , wherein the dioxygenasehas an amino acid sequence similarity to SEQ ID No. 1 of at least 80% measured using the Waterman-Smith algorithm with a gap open penalty of 10, a gap extension penalty of 0.5 and the Blosum62 matrix; andhas an amino acid sequence according to SEQ ID No. 2.4. The method according to claim 2 , wherein the dioxygenase has a peroxidase activity of at most 0.4 nkat/mg guaiacol/2-hydroperoxypalmitic acid.5. The method according to claim 1 , wherein the fatty acid is selected from the group consisting of:linear or branched saturated fatty acids;linear or branched unsaturated fatty acids; andunsaturated or saturated fatty acids with 1 to 5 substituents, wherein the substituents are in each case selected independently from hydroxy, C1-C10-alkyl, C1-C10-alkoxy, C6-C10-aryl, phenyl-C1-C5-alkyl and phenyl-C1-C5-alkenyl, wherein the alpha-C atom of the fatty acid does not carry any such substituent.7. The method according to claim 1 , wherein the microorganism cells are selected from microorganismsselected from the group consisting of the classes of gamma proteobacteria, bacilli, and saccharomycetes.8. The method according to claim 1 , wherein applying a conversion medium containing a fatty acid with 6 to 32 ...

Подробнее
13-06-2013 дата публикации

NOVEL CARBONYL REDUCTASE, GENE THEREFOR AND USE THEREOF

Номер: US20130149769A1
Принадлежит: KANEKA CORPORATION

The present invention is to provide a process for efficiently producing an optically active alcohol including (R)-3-hydroxy-3-phenylpropanenitrile. One of the features of the present invention is a polypeptide having an activity of asymmetrically reducing 3-oxo-3-phenylpropanenitrile isolated from a microorganism belonging to the genus to product (R)-3-hydroxy-3-phenylpropanenitrile, DNA encoding the polypeptide and a transformant of producing the polypeptide. Another feature of the present invention is a process for producing an optically active alcohol such as (R)-3-hydroxy-3-phenylpropanenitrile by reducing a carbonyl compound such as 3-oxo-3-phenylpropanenitrile by use of the polypeptide or the transformant. 1(a) an isolated polypeptide having an amino acid sequence of SEQ ID NO: 2, and(b) an isolated polypeptide with at least 90% amino acid sequence identity to SEQ ID NO: 2, and wherein said polypeptide has an activity of asymmetrically reducing 3-oxo-3-phenylpropanenitrile represented by the formula (1) below;. An isolated polypeptide selected from the group consisting of:to produce (R)-3-hydroxy-3-phenylpropanenitrile represented by the formula (2) below; This is a divisional application of U.S. patent application Ser. No. 11/665,065, filed Apr. 11, 2007 (allowed), which is a 371 National Stage Entry of International Application No. PCT/JP05/19269, filed Oct. 20, 2005, which claims benefit from Japanese Patent Application No. 2004-312365, filed Oct. 27, 2004, the contents of each of which are incorporated herein by reference in their entirety.The present invention relates to a polypeptide (carbonyl reductase) having an activity of asymmetrically reducing 3-oxo-3-phenylpropanenitrile represented by the formula (1) below:to produce (R)-3-hydroxy-3-phenylpropanenitrile represented by the formula (2) below:and isolated from a microorganism having said activity; DNA encoding the polypeptide; a vector containing the DNA; and a transformant transformed with the ...

Подробнее
13-06-2013 дата публикации

Marchantiales-derived unsaturated fatty acid synthetase genes and use of the same

Номер: US20130152229A1
Автор: Kanji Ohyama
Принадлежит: Suntory Holdings Ltd

A Δ5 fatty acid desaturase gene, a Δ6 fatty acid desaturase gene, and a Δ6 fatty-acid-chain elongase gene are isolated from a single species of Marchantiales. By introducing these genes into higher plants, transformed plants which can produce arachidonic acid and eicosapentaenoic acid (EPA) are obtained.

Подробнее
13-06-2013 дата публикации

Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake

Номер: US20130152231A1
Принадлежит: PIONEER HI BRED INTERNATIONAL INC

The present invention provides methods and compositions relating to altering NT activity, nitrogen utilization and/or uptake in plants. The invention relates to a method for the production of plants with maintained or increased yield under low or normal nitrogen fertility. The invention provides isolated nitrate transporter (NT) nucleic acids and their encoded proteins. The invention further provides recombinant expression cassettes, host cells, and transgenic plants. Plants transformed with nucleotide sequences encoding the NT enzyme show improved properties, for example, increased yield.

Подробнее
20-06-2013 дата публикации

CATALYTIC DOMAINS FROM LYSYL OXIDASE AND LOXL2

Номер: US20130157361A1
Принадлежит: Gilead Biologics, Inc.

Disclosed herein are amino acid sequences, and encoding nucleotide sequences, of isolated catalytic domains of the LOX and LOXL2 proteins from human and mouse. Methods for the preparation and use of these isolated catalytic domains are also provided. 1. An isolated polynucleotide , comprising:a nucleotide sequence encoding a polypeptide comprising a catalytic domain of a human or murine LOX or LOXL2 protein, wherein:the polypeptide comprises the amino acid sequence selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO: 1 without the initial GL residues, SEQ ID NO: 3 or SEQ ID NO: 3 without the initial TA residues, SEQ ID NO:5, SEQ ID NO:5 without the initial GL residues, and SEQ ID NO:7, SEQ ID NO:7 without the initial TA residues; andthe polypeptide does not contain sequences from the human or murine LOX or LOXL2 protein outside its catalytic domain.2. The isolated polynucleotide of claim 1 , wherein the polynucleotide is a cDNA.3. The isolated polynucleotide of claim 1 , wherein the polynucleotide encoding the polypeptide does not contain introns.4. The polynucleotide of claim 1 , wherein the polypeptide comprises the amino acid sequence set forth in SEQ ID NO:1.5. The polynucleotide of claim 1 , wherein the polypeptide comprises the amino acid sequence set forth in SEQ ID NO:3.6. The polynucleotide of claim 1 , wherein the polypeptide comprises the amino acid sequence set forth in SEQ ID NO:5.7. The polynucleotide of claim 1 , wherein the polypeptide further comprising a signal sequence claim 1 , an epitope tag and a purification tag.8. The polynucleotide of claim 7 , wherein the signal sequence is an immunoglobulin kappa signal sequence.9. The polynucleotide of claim 7 , wherein the epitope tag is myc tag.10. The polynucleotide of claim 7 , wherein the purification tag is a His6 tag.11. An expression vector comprising the polynucleotide of .12. A recombinant host cell comprising the expression vector of . This application is a divisional of U.S. ...

Подробнее
20-06-2013 дата публикации

Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose

Номер: US20130158239A1

Described herein are methods and genetically engineered cells useful for uncapping a mannose-6-phosphate residue on an oligosaccharide.

Подробнее
27-06-2013 дата публикации

METHOD FOR SECRETORY PRODUCTION OF GLYCOPROTEIN HAVING HUMAN-TYPE SUGAR CHAIN USING PLANT CELL

Номер: US20130164782A1
Принадлежит: Phyton Holdings, LLC

A method for the secretory production of a glycoprotein having a human-type sugar chain, comprising a step of introducing a gene of an enzyme capable of performing a transfer reaction of a galactose residue to a non-reducing terminal acetylglucosamine residue, and a gene of heterologous glycoprotein, to obtain a transformed plant cell, a step of culturing the plant cell, and a step of recovering the culture medium of the plant cell. 114.-. (canceled)15. A method for producing a secretory glycoprotein having a human-type sugar chain from a transgenic plant cell , the method comprising:providing a transgenic plant cell that comprises a first heterologous nucleic acid sequence encoding an β1,4-galactosyltransferase and a second heterologous nucleic acid sequence encoding a heterologous glycoprotein, wherein the transgenic plant cell has suppressed activity of an endogenous β1,2-xylose transfer enzyme, α1,3-fucose transfer enzyme, or both; andculturing the transgenic plant cell in a culture medium to allow production and secretion of the heterologous glycoprotein, which contains an N-glycan having a galactose residue linked to a non-reducing terminal acetylglucosamine residue; andcollecting the culture medium for isolation of the heterologous glycoprotein.16. The method of claim 15 , further comprising recovering the heterologous glycoprotein from the culture medium.17. The method of claim 15 , wherein the transgenic plant cell has the endogenous gene encoding the β1 claim 15 ,2-xylose transfer enzyme or the endogenous α1 claim 15 ,3-fucose transfer enzyme inactivated.18. The method of claim 15 , wherein the transgenic plant cell has the endogenous genes encoding both the β1 claim 15 ,2-xylose transfer enzyme and the α1 claim 15 ,3-fucose transfer enzyme inactivated.19. The method of claim 15 , wherein the culture medium comprises an agent that increases the concentration of the heterologous glycoprotein in the culture medium.20. The method of claim 19 , wherein the ...

Подробнее
27-06-2013 дата публикации

FUCOSYLATION-DEFICIENT CELLS

Номер: US20130164786A1
Принадлежит: Regeneron Pharmaceuticals, Inc.

An isolated nucleic acid encoding an FX protein having a serine at position a lysine at position a leucine at position an arginine at position a serine at position and a combination thereof is provided. Cells having a gene encoding a modified FX protein are provided, wherein the cells exhibit a reduced ability to fucosylate a glycoprotein at a first temperature, but exhibit the ability to fucosylate the glycoprotein at a second temperature. Methods and compositions for making glycoproteins with reduced fucosylation are provided. 1. A cell capable of fucosylating a glycoprotein , wherein the cell comprises a modified GDP-4-keto-6-deoxy-mannose-3 ,5-epimerase-4-reductase (FX) gene comprising SEQ ID NO:1 having a modification that encodes for a serine at position 289 , and wherein no more than about 10% of the glycoprotein is fucosylated when the cell is grown at a temperature of about 37° C. in the absence of an external fucose source.2. The cell of claim 1 , wherein the FX gene further comprises a modification that encodes for an amino acid at a specific position selected from the group consisting of a serine at position 79 claim 1 , a lysine at position 90 claim 1 , a leucine at position 136 claim 1 , an arginine at position 211 claim 1 , and a combination thereof.3. The cell of claim 1 , wherein the cell is a Chinese hamster ovary (CHO) cell.4. The cell of claim 1 , wherein the cell expresses a glycoprotein that comprises an immunoglobulin CH2 region and an immunoglobulin CH3 region.5. The cell of claim 4 , wherein the glycoprotein is an antibody.6. The cell of claim 4 , wherein no more than about 6% of the glycoprotein is fucosylated when the cell is grown at a temperature of about 37° C. in the absence of an external fucose source.7. The cell of claim 6 , wherein no more than about 2% of the glycoprotein is fucosylated when the cell is grown at a temperature of about 37° C. in the absence of an external fucose source.8. The cell of claim 1 , wherein the cell ...

Подробнее
27-06-2013 дата публикации

METHOD OF TREATING OBESITY AND METABOLIC DISORDERS RELATED TO EXCESS ADIPOSE TISSUE BY ADMINISTRATION OF sFRP-- PEPTIDE

Номер: US20130165369A1
Принадлежит: HMGENE Inc

Disclosed is a method of reducing the amount of adipose tissue in a subject comprising administering to the subject an amount of an sFRP-5 peptide effective to reduce the amount of adipose tissue, or an amount of a molecule effective to stimulate expression of the sFRP-5 peptide in the subject. Also disclosed is a screen for molecules that can reduce the amount of adipose tissue in a subject.

Подробнее